Y
Yang Liu
Researcher at Harbin Medical University
Publications - 17
Citations - 438
Yang Liu is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Dysbiosis & Gut flora. The author has an hindex of 8, co-authored 17 publications receiving 213 citations.
Papers
More filters
Journal ArticleDOI
Alterations of the Gut Microbiota in Hashimoto's Thyroiditis Patients
TL;DR: Characterization of the gut microbiota in HT patients confirmed that HT patients have altered gut microbiota and that gut microbiota are correlated with clinical parameters, suggesting that microbiome composition data could be used for disease diagnosis.
Journal ArticleDOI
Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients
Jing Feng,Fuya Zhao,Jiayu Sun,Baiqiang Lin,Lei Zhao,Yang Liu,Ye Jin,Shengda Li,Aidong Li,Yunwei Wei +9 more
TL;DR: This study presents a comprehensive landscape of the gut microbiota and metabolites in TC patients, and provides a research direction of the mechanism of interaction between gut microbiota alteration and TC pathogenesis.
Journal ArticleDOI
Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
Huinan Chen,Biqiang Zhu,Lei Zhao,Yang Liu,Fuya Zhao,Jing Feng,Ye Jin,Jiayu Sun,Rui Geng,Yunwei Wei +9 more
TL;DR: The findings suggest that allicin suppresses cell proliferation and invasion via STAT3 signaling and may be a potential therapeutic agent for CCA.
Journal ArticleDOI
Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality.
TL;DR: In this paper, the authors summarized the biological characteristics of Fusobacterium nucleatum and the epidemiological associations between F. nucleatum, and highlighted the mechanisms by which F.ucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment.
Journal ArticleDOI
Splenectomy Leads to Amelioration of Altered Gut Microbiota and Metabolome in Liver Cirrhosis Patients
TL;DR: Dysbiosis in gut microbiome and related metabolism of LC patients was partially corrected after splenectomy, and the improved gut microenvironment could prevent LC-related complications and delay the progress of LC is a propitious objective for future study.